Presentation TCT 2022 TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease. Presenter: Marta Konopko September 17, 2022 REGISTER for free or LOG IN to view this content Coronary TCT 2022 Up Next Presentation TCT 2022 TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption Presenter: Gabriele Pesarini September 17, 2022 More slides + Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022 Presentation TCT 2022 TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry. Presenter: Giulia Masiero September 17, 2022 We Recommend
Presentation TCT 2022 TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption Presenter: Gabriele Pesarini September 17, 2022
Presentation TCT 2022 TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes Presenter: Matthias Lutz September 17, 2022
Presentation TCT 2022 TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry. Presenter: Giulia Masiero September 17, 2022